11/7
04:11 pm
lenz
LENZ Therapeutics, Inc. (NASDAQ: LENZ) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $38.00 price target on the stock.
Medium
Report
LENZ Therapeutics, Inc. (NASDAQ: LENZ) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $38.00 price target on the stock.
9/27
01:07 pm
lenz
Rating for LENZ
Low
Report
Rating for LENZ
9/27
01:07 pm
lenz
Rating for LENZ
Low
Report
Rating for LENZ
9/27
07:41 am
lenz
LENZ Therapeutics, Inc. (NASDAQ: LENZ) is now covered by analysts at Raymond James. They set an "outperform" rating and a $37.00 price target on the stock.
Medium
Report
LENZ Therapeutics, Inc. (NASDAQ: LENZ) is now covered by analysts at Raymond James. They set an "outperform" rating and a $37.00 price target on the stock.
9/27
07:41 am
lenz
LENZ Therapeutics, Inc. (NASDAQ: LENZ) is now covered by analysts at Raymond James. They set an "outperform" rating and a $37.00 price target on the stock.
Medium
Report
LENZ Therapeutics, Inc. (NASDAQ: LENZ) is now covered by analysts at Raymond James. They set an "outperform" rating and a $37.00 price target on the stock.
9/26
04:27 pm
lenz
Lenz Therapeutics initiated with bullish view at Raymond James
Medium
Report
Lenz Therapeutics initiated with bullish view at Raymond James
9/26
04:27 pm
lenz
Lenz Therapeutics initiated with bullish view at Raymond James
Medium
Report
Lenz Therapeutics initiated with bullish view at Raymond James
9/6
06:59 am
lenz
LENZ Therapeutics, Inc. (NASDAQ: LENZ) was upgraded by analysts at William Blair to a "strong-buy" rating.
Low
Report
LENZ Therapeutics, Inc. (NASDAQ: LENZ) was upgraded by analysts at William Blair to a "strong-buy" rating.
9/6
06:59 am
lenz
LENZ Therapeutics, Inc. (NASDAQ: LENZ) was upgraded by analysts at William Blair to a "strong-buy" rating.
Low
Report
LENZ Therapeutics, Inc. (NASDAQ: LENZ) was upgraded by analysts at William Blair to a "strong-buy" rating.